BRIEF-CSPC Pharmaceutical Group Updates on Drug Registration Approval For Injection By China FDA
May 10 (Reuters) - CSPC Pharmaceutical Group Ltd:
* CSPC PHARMACEUTICAL GROUP-"DOXOFYLLINE GLUCOSE FOR INJECTION" GRANTED DRUG REGISTRATION APPROVAL BY CHINA FDA
* "DOXOFYLLINE SODIUM CHLORIDE FOR INJECTION" GRANTED DRUG REGISTRATION APPROVAL BY CHINA FDA Source text for Eikon: Further company coverage: